![]() All statements other than statements of historical fact, including those that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance, including the Company’s net revenue guidance for the second quarter, are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties that could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “potential”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, “believes”, or “projects”, or the negatives thereof or variations of such words and phrases or statements that certain actions, events or results “will”, “should”, “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” or the negative of these terms or comparable terminology. Private Securities Litigation Reform Act of 1995 or “forward-looking information” as such term is defined in applicable Canadian securities legislation (collectively, “forward-looking statements”). Visit our website at For further information, please contact:Ĭertain statements contained in this press release may constitute “forward-looking statements” within the meaning of the U.S. Viemed’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counseling to patients in their homes using cutting edge technology. Viemed is a provider of in-home medical equipment and post-acute respiratory healthcare services in the United States. Interested parties may participate in the call by dialing:įollowing the conclusion of the call, an audio recording and transcript of the call can be accessed on the Company’s website. The Company will host a conference call to discuss first quarter results on Tuesday, at 11:00 a.m. Our recent acquisition initiatives are the natural progression of strategic investments that create a better experience for patients, physicians, and payors, and will ultimately allow us to expand care to those in need.” “We are excited to amplify our robust organic growth through accretive acquisitions that create powerful revenue synergies, diversify our offerings, and build upon strong relationships with stakeholders. ![]() “Our recently announced operating results demonstrate that the core business is firing on all cylinders,” said Casey Hoyt, Viemed’s CEO. The Company expects to generate net revenues attributable to its core business of approximately $40.2 million to $41.2 million during the second quarter of 2023, excluding the impact from any acquired revenues during the period.(“HMP”), a large regional provider of respiratory focused home medical solutions, which generated annual net revenues of approximately $28 million in 2022. The Company recently announced that it has entered into a definitive agreement to acquire Tennessee based Home Medical Products, Inc.The Company had no long term debt outstanding as of March 31, 2023. The Company increased its cash balance by approximately 39% to $23.5 million at Macompared to $16.9 million at December 31, 2022, and increased its overall working capital balance to $23.3 million at Macompared to $20.9 million at December 31, 2022.GAAP financial measures can be found in the tables accompanying this press release. A reconciliation of reported non-GAAP financial measures to their most directly comparable U.S. Adjusted EBITDA for the quarter ended Matotaled $8.3 million, a 15% increase as compared to the quarter ended Mawhich benefited from COVID-19 related revenue and Provider Relief Fund income. Net income for the quarter ended Matotaled $1.5 million.Net revenues for the quarter ended Mawere up approximately 6% over the quarter ended December 31, 2022. Net revenues attributable to the Company’s core business for the quarter ended Mawere $39.6 million, a new Company record, and an increase of $9.4 million, or 31%, over the quarter ended March 31, 2022.Operational highlights (all dollar amounts are USD): ![]() (the “Company” or “Viemed”) (NASDAQ:VMD and TSX: VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, today announced its financial results for the three months ended March 31, 2023. LAFAYETTE, La., (GLOBE NEWSWIRE) - Viemed Healthcare, Inc.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |